104 filings
Page 4 of 6
6-K
ag2o4zg78nbt
22 Sep 20
Aslan Pharmaceuticals Completes Enrolment In Second Cohort and Opens New Sites In Us and Australia In ASLAN004 Atopic Dermatitis Study
12:00am
6-K
wq4b42yx slc5b4h5uu
17 Sep 20
Current report (foreign)
5:02pm
6-K
gmk10dwb
4 Sep 20
Current report (foreign)
10:14am
6-K
zje0fxea4cr6
24 Aug 20
Aslan Pharmaceuticals Resumes Recruitment of New Patients into ASLAN004 Study
9:25am
6-K
kk9l4m2av9sq37dp
3 Aug 20
Aslan Pharmaceuticals Appoints Kenneth Kobayashi, MD, As Chief Medical Officer
6:24am
6-K
wfu79
17 Jul 20
Aslan Pharmaceuticals Announces the Move of Its Primary Listing to Nasdaq and Delisting from Taipei Exchange
6:03am
6-K
9fso dtqps8a
13 Jul 20
Aslan Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Corporate Update
12:30pm
6-K
hy707iri
15 Jun 20
Current report (foreign)
6:04am
6-K
dbmiqeeas
9 Jun 20
Current report (foreign)
4:31pm
6-K
yrx5rgmcjo
11 May 20
Aslan Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Corporate Update
9:37pm
6-K
kcdbc0rzvxf8e55i1cn
5 May 20
Current report (foreign)
6:02am
6-K
odztvmpndhf3a4h4zkfb
13 Apr 20
Aslan Pharmaceuticals Temporarily Pauses Recruitment of New Patients into ASLAN004 Study Due to COVID-19
10:14am
6-K
vh6b49k
23 Mar 20
Current report (foreign)
6:02am
6-K
e8t3o769nmp0l z0vrr
19 Mar 20
Aslan Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update
6:02am
6-K
hu66n viybz
19 Mar 20
Current report (foreign)
6:02am
6-K
lwh67nvc81lnllq
7 Jan 20
Current report (foreign)
7:56am
6-K
61j8vneohof v37
5 Dec 19
Aslan Pharmaceuticals Announces Proposed Public Offering of American Depositary Shares
6:09am
6-K
h54pk 5qggz
2 Dec 19
Aslan Pharmaceuticals Reports Positive Preliminary Data Fromproof-of-concept Study for ASLAN004 Targeting Atopic Dermatitis
4:01pm
6-K
b12xtd
12 Nov 19
Aslan Pharmaceuticals Announces Topline Results from Treetopp Global Pivotal Study of Varlitinib In Biliary Tract Cancer
6:03am
6-K
jsroh72vskjan9 cm5
5 Nov 19
Current report (foreign)
6:04am